These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9030825)

  • 81. Angiotension converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats.
    Yavuz DG; Tuğlular S; Koçak H; Atakan A; Ozener C; Akoğlu E; Akalin S
    Transplant Proc; 2004; 36(1):171-4. PubMed ID: 15013337
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Possible synergistic effect of ACE inhibition and calcium-channel blockade on insulin sensitivity in insulin-resistant type II diabetic hypertensive patients.
    Rett K; Jacob S; Wicklmayr M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S29-33. PubMed ID: 7519694
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Metabolic effects of quinapril in hepertensive patients].
    Zonis BIa; Volkova NI; Martirosov VIu; Kharakhashian AV
    Ter Arkh; 2000; 72(1):45-7. PubMed ID: 10687206
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The pharmacodynamic responses of hypertensive patients to quinapril therapy.
    Fernandez PG; Snedden W
    Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 87. B cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects.
    Bonora E; Moghetti P; Zenere M; Tosi F; Travia D; Muggeo M
    Int J Obes; 1990 Sep; 14(9):735-42. PubMed ID: 2228406
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling.
    Nong Z; Stassen JM; Moons L; Collen D; Janssens S
    Circulation; 1996 Oct; 94(8):1941-7. PubMed ID: 8873672
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans.
    Uehara M; Kishikawa H; Isami S; Kisanuki K; Ohkubo Y; Miyamura N; Miyata T; Yano T; Shichiri M
    Diabetologia; 1994 Mar; 37(3):300-7. PubMed ID: 8174845
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypertension and insulin disorders.
    Imazu M
    Curr Hypertens Rep; 2002 Dec; 4(6):477-82. PubMed ID: 12419178
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition.
    Laviades C; Gil MJ; Monreal I; González A; Díez J
    J Hypertens; 1998 Jun; 16(6):863-70. PubMed ID: 9663927
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Insulin resistance is a characteristic feature of primary hypertension independent of obesity.
    Pollare T; Lithell H; Berne C
    Metabolism; 1990 Feb; 39(2):167-74. PubMed ID: 2405235
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
    Sasaki H; Naka K; Kishi Y; Ohoshi T; Hagihara T; Matsuo H; Sowa R; Matsumoto G; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1994 Nov; 26(1):67-75. PubMed ID: 7533075
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lack of effect of nicardipine and diltiazem on glucose- and arginine-induced insulin release in obese subjects.
    Pezzarossa A; Cimicchi MC; Orlandi N; Gnudi A; Manca C; Perrone A; Bolognesi R
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):669-72. PubMed ID: 3154642
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of ramipril therapy on some components of insulin resistance syndrome in patients with essential hypertension.
    Bojović L; Micić D
    Med Pregl; 2002; 55(7-8):286-92. PubMed ID: 12434673
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Beta-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model.
    Toffolo G; Cefalu WT; Cobelli C
    Metabolism; 1999 Sep; 48(9):1162-6. PubMed ID: 10484058
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cytosolic calcium and insulin resistance.
    Draznin B
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):32-8. PubMed ID: 8503433
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Body composition and glucose metabolism in hypertensive middle-aged males.
    Berglund G; Larsson B; Andersson O; Larsson O; Svärdsudd K; Björntorp P; Wilhelmsen L
    Acta Med Scand; 1976; 200(3):163-9. PubMed ID: 970224
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
    Kailasam MT; Parmer RJ; Tyrell EA; Henry RR; O'Connor DT
    J Hypertens; 2000 Nov; 18(11):1611-20. PubMed ID: 11081774
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension.
    de Courten M; Ferrari P; Schneider M; Böhlen L; Shaw S; Riesen W; Heynen G; Weidmann P
    Eur J Clin Pharmacol; 1993; 44(5):457-62. PubMed ID: 8359183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.